Navigation Links
2 Cleveland Clinic researchers honored for contribution to science
Date:11/25/2013

Monday, Nov. 25, 2013, Cleveland: Cleveland Clinic researchers Richard A. Padgett, Ph.D., and Edward F. Plow, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS). This year's AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on Nov. 29, 2013.

Dr. Padgett, who works in the Department of Molecular Genetics at the Lerner Research Institute, was elected as an AAAS Fellow for distinguished contributions to the field of RNA processing, particularly in the areas of RNA splicing, the diversity of splicing mechanisms, and connections with disease.

RNA, or ribonucleic acid, is a nucleic acid present in all living cells that translates the genetic code (DNA) into proteins. RNA splicing is the processing of RNA to remove portions that do not encode proteins. Many diseases are either caused by or associated with mistakes in the splicing process or mutations in the splicing machinery. Dr. Padgett's research aims to understand how these errors in RNA splicing lead to disease, such as cancer, and how the errors can be corrected.

Dr. Plow, Department Chair of Molecular Cardiology at the Lerner Research Institute, and The Robert C. Tarazi, M.D., Endowed Chair in Heart and Hypertension Research, is being honored as an AAAS Fellow for distinguished contributions to vascular biology, particularly for elucidating mechanisms of platelets, integrins, and plasminogen, and outstanding services to the cardiovascular community.

Dr. Plow's research involves dissecting the cellular mechanisms underlying hypertension and heart disease. Specifically, he studies the role of integrins, a type of cell adhesion molecule involved in blood coagulation, in cardiovascular disease. He also recently discovered that the blood protein plasminogen, which has long been associated with coronary artery disease, and a related enzyme are essential in the formation of foam cells-- a hallmark of advanced atherosclerosis, or hardening of the arteries.

Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers. This year 388 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications.


'/>"/>

Contact: Laura Ambro
ambrol@ccf.org
216-636-5876
Cleveland Clinic
Source:Eurekalert

Related biology news :

1. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
2. Cleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer
3. Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients
4. Cleveland Clinic researchers discover new link between heart disease and red meat
5. Cleveland Clinic research shows gut bacteria byproduct predicts heart attack and stroke
6. Cleveland Clinics 2013 Obesity Summit explores causes, prevention and treatment of obesity
7. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. New clinical trial explores novel noninvasive colon cancer screening test
10. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... 2017  Michael Johnson, co-founder of Visikol Inc. a company originally ... been named to the elite "Forbes 30 Under 30" list in ... people in 20 fields nationwide to be recognized as a leader ... were selected. ... is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)... Jan. 4, 2017  For the thousands of attendees at this year,s ... in connected health and biometric measurement devices and services, will be featuring ... On display in A&D Medical,s special CES Exhibit Suite , the ... expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 18, 2017 , ... The ... (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, ... subject to the existing policy. AMIA recommended that NIH earmark funding for researchers ...
(Date:1/19/2017)... 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), ... for operable and inoperable solid tumor cancers, announced today ... of NW Bio, will present at the Phacilitate Immunotherapy ... Hyatt Regency Hotel in Miami, Florida ... entitled "New Therapeutic Approaches – Expanding the Reach of ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017   Boston ... novel compounds designed to target cancer stemness pathways, will ... investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers ... Francisco . Napabucasin is an ... by targeting STAT3. i Cancer stem cells (CSCs) ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has furthered ... Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables & ... further growth in 2017. Extractable & Leachable evaluations have become increasingly more vital ...
Breaking Biology Technology: